Even if the trialssucceed, another concern is that because the device is threaded into the heart, it carries its own risk for complications as an invasive procedure.
It has an exclusive option to repurchase its rights to the three drugs for a preset price, which it will likely do if the clinical trialssucceed on its cholesterol-lowering drug, called 301012.